EGFR and EGFRvIII in Glioblastoma: Partners in Crime

Cancer Cell - United States
doi 10.1016/j.ccr.2013.09.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma

Frontiers in Oncology
Cancer ResearchOncology
2015English

EGFR Cooperates With EGFRvIII to Recruit Macrophages in Glioblastoma

Cancer Research
Cancer ResearchOncology
2018English

Metabolic Targeting of EGFRvIII/PDK1 Axis in Temozolomide Resistant Glioblastoma

Oncotarget
Oncology
2017English

P376: Dirty Bedpans and MDRO: Partners in Crime?

Antimicrobial Resistance and Infection Control
PharmacologyPublic HealthMicrobiologyEnvironmentalInfectious DiseasesOccupational Health
2013English

Lessons Learned From Rindopepimut Treatment in Patients With EGFRvIII-expressing Glioblastoma

Translational Cancer Research
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2018English

LRRK2 and Neuroinflammation: Partners in Crime in Parkinson’s Disease?

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Partners in Crime: Fledgling Tumors Hijack Inflammation

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2019English

EGFR and mTOR as Therapeutic Targets in Glioblastoma

Oncotarget
Oncology
2019English

The Engagement Between MDSCs and Metastases: Partners in Crime

Frontiers in Oncology
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy